Four Republican senators are pressing FDA about charges from industry that the agency is using draft guidance documents to make substantive policy changes.
The lawmakers want information from FDA on guidelines that currently remain in the draft stage, the agency’s plans for finalizing those guidances, and FDA’s policies for ensuring that its staff...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?